Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

被引：22

作者：

Collins, Graham P. ^{[1
]}

Parker, Anne N. ^{[2
]}

Pocock, Christopher ^{[3
]}

Kayani, Irfan ^{[4
]}

Sureda, Anna ^{[5
]}

Illidge, Tim ^{[6
]}

Ardeshna, Kirit ^{[7
]}

Linch, David C. ^{[7
,8
]}

Peggs, Karl S. ^{[7
,8
]}

机构：

[1] Churchill Hosp, Oxford Canc & Haematol Ctr, Dept Haematol, Oxford OX3 7LJ, England

[2] Beatson West Scotland Canc Ctr, HPC Transplant Programme, Glasgow, Lanark, Scotland

[3] East Kent Hosp NHS Trust, Dept Haematol, Canterbury, Kent, England

[4] Univ Coll London Hosp NHS Trust, Dept Nucl Med, London, England

[5] Univ Cambridge, Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England

[6] Univ Manchester, Christie Hosp, Inst Canc Sci, Manchester, Lancs, England

[7] Univ Coll London Hosp NHS Trust, Dept Haematol, London, England

[8] UCL, Inst Canc, Dept Haematol, London WC1E 6BT, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 164卷 / 01期

关键词：

Hodgkin lymphoma; relapse; chemotherapy; transplantation; STEM-CELL-TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; BONE-MARROW-TRANSPLANTATION; INVOLVED FIELD RADIOTHERAPY; BLOOD PROGENITOR-CELL; SALVAGE THERAPY; BRENTUXIMAB VEDOTIN; PROGNOSTIC-FACTORS; MINI-BEAM; RADIATION-THERAPY;

D O I：

10.1111/bjh.12582

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：39 / 52

页数：14

共 89 条

[51] Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation [J].

Peggs, KS ;

Hunter, A ;

Chopra, R ;

Parker, A ;

Mahendra, P ;

Milligan, D ;

Craddock, C ;

Pettengell, R ;

Dogan, A ;

Thomson, KJ ;

Morris, EC ;

Hale, G ;

Waldmann, H ;

Goldstone, AH ;

Linch, DC ;

Mackinnon, S .

LANCET, 2005, 365 (9475) :1934-1941

[52] LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre [J].

Perz, J. B. ;

Giles, C. ;

Szydlo, R. ;

O'Shea, D. ;

Sanz, J. ;

Chaidos, A. ;

Wagner, S. ;

Davis, J. ;

Loaiza, S. ;

Marin, D. ;

Apperley, J. ;

Olavarria, E. ;

Rahemtulla, A. ;

Lampert, I. ;

Naresh, K. ;

Samson, D. ;

MacDonald, D. ;

Kanfer, E. J. .

BONE MARROW TRANSPLANTATION, 2007, 39 (01) :41-47

[53] High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival [J].

Poen, JC ;

Hoppe, RT ;

Horning, SJ .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (01) :3-12

[54] The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control [J].

Proctor, S. J. ;

Lennard, A. L. ;

Jackson, G. H. ;

Jones, G. L. ;

Lewis, J. ;

Wilkinson, J. ;

White, J. ;

Sieniawski, M. ;

McKay, P. ;

Culligan, D. ;

Lucraft, H. H. .

ANNALS OF ONCOLOGY, 2010, 21 (02) :426-428

[55]

Proctor SJ, 2001, EUR J HAEMATOL, V66, P28

[56] Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study [J].

Provencio, Mariano ;

Salas, Clara ;

Millan, Isabel ;

Cantos, Blanca ;

Sanchez, Antonio ;

Bellas, Carmen .

LEUKEMIA & LYMPHOMA, 2010, 51 (09) :1686-1691

[57] Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma [J].

Rapoport, AP ;

Guo, C ;

Badros, A ;

Hakimian, R ;

Akpek, G ;

Kiggundu, E ;

Meisenberg, B ;

Mannuel, H ;

Takebe, N ;

Fenton, R ;

Bolaños-Meade, J ;

Heyman, M ;

Gojo, I ;

Ruehle, K ;

Natt, S ;

Ratterree, B ;

Withers, T ;

Sarkodee-Adoo, C ;

Phillips, GL ;

Tricot, G .

BONE MARROW TRANSPLANTATION, 2004, 34 (10) :883-890

[58] Oxaliplatin-Based Chemotherapy (Dexamethasone, High-Dose Cytarabine, and Oxaliplatin) ± Rituximab Is an Effective Salvage Regimen in Patients With Relapsed or Refractory Lymphoma [J].

Rigacci, Luigi ;

Fabbri, Alberto ;

Puccini, Benedetta ;

Chitarrelli, Ida ;

Chiappella, Annalisa ;

Vitolo, Umberto ;

Levis, Alessandro ;

Lauria, Francesco ;

Bosi, Alberto .

CANCER, 2010, 116 (19) :4573-4579

[59] Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome [J].

Robinson, Stephen P. ;

Sureda, Anna ;

Canals, Carmen ;

Russell, Nigel ;

Caballero, Dolores ;

Bacigalupos, Andrea ;

Iriondo, Arturo ;

Cook, Gordon ;

Pettitt, Andrew ;

Socie, Gerard ;

Bonifazi, Francesca ;

Bosi, Alberto ;

Michallet, Mauricette ;

Liakopoulou, Effie ;

Maertens, Johan ;

Passweg, Jakob ;

Clarke, Fiona ;

Martin, Rodrigo ;

Schmitz, Norbert .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02) :230-238

[60] ASHAP: A regimen for cytoreduction of refractory or recurrent Hodgkin's disease [J].

Rodriguez, J ;

Rodriguez, MA ;

Fayad, L ;

McLaughlin, P ;

Swan, F ;

Sarris, A ;

Romaguera, J ;

Andersson, B ;

Cabanillas, F ;

Hagemeister, FB .

BLOOD, 1999, 93 (11) :3632-3636

← 1 2 3 4 5 6 7 8 9 →